Allison Humphries's Publications

About Allison Humphries's Publications

Senior Research Fellow, Respiratory Programme
  • Operations Lead, Academic Project Operations

  • Simplification with fixed-dose tenofovir-emtricitabine or abacavir-lamivudine in treatment experienced, virologically suppressed adults with HIV infection: combined analysis of two randomized, non-inferiority trials BICOMBO and STEAL.

    Journal of AIDS & Clinical Research Date published:

  • Simplification with Fixed-Dose Tenofovir-Emtricitabine or Abacavir-Lamivudine in Treatment Experienced, Virologically Suppressed Adults with Hiv Infection: Combined Analysis of Two Randomised, Non-Inferiority Trials Bicombo and Steal

    Journal of AIDS & Clinical Research Date published:

  • Simplification of Antiretroviral Therapy with Tenofovir-Emtricitabine or Abacavir-Lamivudine: A Randomized, 96-Week Trial

    Clinical Infectious Diseases Date published:

  • Metabolic disorders and cardiovascular consequences of HIV infection and antiretroviral therapy

    Expert Review of Clinical Pharmacology Date published:

  • Adiponectin isoform distribution in women-relationship to female sex steroids and insulin sensitivity

    Metabolism Date published:

  • Serum Adiponectin Levels in Normal and Hypertensive Pregnancy

    Hypertension in Pregnancy Date published:

  • Evaluation of ultrasound for assessing facial lipoatrophy in a randomized, placebo-controlled trial

    AIDS Date published:

  • Therapeutic approaches to combating lipoatrophy: do they work?

    Journal of Antimicrobial Chemotherapy Date published:

  • Influence of Rosiglitazone on Flow-Mediated Dilation and Other Markers of Cardiovascular Risk in HIV-Infected Patients with Lipoatrophy

    Antiviral Therapy Date published:

  • Progression of Lipodystrophy (LD) with Continued Thymidine Analogue Usage: Long-Term Follow-Up from a Randomized Clinical Trial (The PIILR Study)

    HIV Clinical Trials Date published:

  • Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir

    AIDS Date published:

  • No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial

    The Lancet Date published:

  • Progression of lipodystrophy (LD) with continued thymidine analogue usage; long-term follow up of a randomized clinical trial (The PIILR study).

    HIV Clinical Trials Date published:

  • Reversibility of lipoatrophy in HIV infected patients after switching from a thymidine analogue to abacavir

    AIDS Date published:

  • Rosiglitazone for HIV lipoatrophy: 84 weeks follow-up

    Antiviral Therapy Date published:

  • No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial.

    LANCET Date published: